SCHEMBL7617104

SCHEMBL7617104

O=C(Nc1nnc(C(F)(F)F)s1)c1c(O)c2ccc(C(F)(F)F)cc2oc1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.53
▸ MEN1 O00255 4/20 0.53
▸ NPC1 O15118 6/20 0.50
▸ HTT P42858 5/20 0.50
▸ RAB9A P51151 5/20 0.50
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ TP53 P04637 2/20 0.45
▸ LMNA P02545 3/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ TAS1R3 Q7RTX0 1/20 0.43
▸ TAS1R1 Q7RTX1 1/20 0.43
▸ TAS1R2 Q8TE23 1/20 0.43
▸ MAPT P10636 3/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ ATM Q13315 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7620367 0.93 KMT2A (0.45) KMT2AMEN1NPC1HTTRAB9A
SCHEMBL7608938 0.93 KMT2A (0.45) KMT2AMEN1NPC1HTTRAB9A
SCHEMBL7610155 0.90 MEN1 (0.56) KMT2AMEN1NPC1HTTRAB9A
SCHEMBL7618641 0.89 MEN1 (0.52) KMT2AMEN1NPC1HTTRAB9A
SCHEMBL9206228 0.89 POLB (0.53) KMT2AMEN1NPC1HTTRAB9A
SCHEMBL7616823 0.87 KMT2A (0.41) KMT2AMEN1NPC1HTTRAB9A
SCHEMBL9207130 0.87 MEN1 (0.53) KMT2AMEN1NPC1HTTRAB9A
SCHEMBL9208153 0.86 NPC1 (0.64) KMT2AMEN1NPC1HTTRAB9A
SCHEMBL9201286 0.86 NPC1 (0.57) KMT2AMEN1NPC1HTTRAB9A
SCHEMBL7610711 0.84 MEN1 (0.49) KMT2AMEN1NPC1HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0869785-B1 4-HYDROXYCOUMARIN-3-CARBOXAMIDES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS UPJOHN CO (US) 2002-08-28 — — EP claimed
EP-0550493-B1 ANTHELMINTIC AND ANTICOCCIDAL 3-CARBAMOYL-4-HYDROXYCOUMARINS, METHOD OF USE AND COMPOSITIONS UPJOHN CO (US) 1995-08-09 — — EP claimed
EP-0550493-A1 ANTHELMINTIC AND ANTICOCCIDAL 3-CARBAMOYL-4-HYDROXYCOUMARINS, METHOD OF USE AND COMPOSITIONS. UPJOHN CO (US) 1993-07-14 — — EP claimed
WO-1992006083-A1 ANTHELMINTIC AND ANTICOCCIDAL 3-CARBAMOYL-4-HYDROXYCOUMARINS, METHOD OF USE AND COMPOSITIONS THE UPJOHN COMPANY (US) 1992-04-16 — — WO claimed
Send feedback